Stocks Hitting 52-Week Lows

Juno Therapeutics Inc JUNO shares reached a new 52-week low of $20.45 as the company disclosed that it has placed JCAR015 Phase II ROCKET trial on clinical hold after 2 patients suffered cerebral edema earlier this week.
BioDelivery Sciences International, Inc. BDSI shares fell 5.9 percent to touch a new 52-week low of $1.60. BioDelivery Sciences shares have dropped 72.13 percent over the past 52 weeks, while the S&P 500 index has increased 5.58 percent in the same period.
Eli Lilly and Co LLY shares reached a new 52-week low of $66.61 after the company’s drug solanezumab failed to meet primary endpoint for the treatment of mild dementia due to Alzheimer's disease in a late-stage study.
AstraZeneca plc (ADR) AZN shares touched a new 52-week low of $26.075. AstraZeneca shares have dropped 22.17 percent over the past 52 weeks, while the S&P 500 index has gained 5.58 percent in the same period.